[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f6METHyOew1ToKFpCSuyz9TysHr395hjNTAzm17s43Xw":8,"$fjmiLHdSZtq4fjsjCYaBgPcAqiZPieayAjZzu8F3zO7o":56,"$f8ktKaMup5mffERaXxNnmHElZtCmfd6yvFz9-9fb7m6Y":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":33,"menus":34,"menuId":36,"type":43,"quality":54,"commentCount":21,"isComment":43},75542,867287,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","侯信明","聊城市第二人民医院","甲状腺乳腺外科","主治医师",111,0,"乳腺癌分期2常用化疗药物的安全用药指南","","https://ystcdn.venuertc.com/venue/AI/3b153309-f208-488e-8761-77c93535b098.jpg","\u003Cdiv class=\"bc-chemo-container\">\n  \u003Ch1 id=\"material_title\" class=\"bc-chemo-title\">\n    乳腺癌分期2常用化疗药物的安全用药指南\n  \u003C/h1>\n\n  \u003Cdiv class=\"bc-chemo-section bc-chemo-intro\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">\n        化疗药物怎么安全用？关键细节一次弄明白 👩‍🔬\n      \u003C/h2>\n      \u003Cp>\n        化疗药物是乳腺肿瘤治疗中非常重要的一类药品，其中，白蛋白紫杉醇、吡柔比星和环磷酰胺在二期患者中应用较多。每种药物的使用方法和注意事项都有讲究，处理不当可能增加风险。本文围绕使用这三种药品的7个安全细节做一次详细梳理，帮助你科学规避用药误区，聪明用药。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">01 白蛋白紫杉醇的作用与特点\u003C/h2>\n      \u003Cp>\n        白蛋白紫杉醇（Nab-Paclitaxel）是一种抗微管药，通过抑制细胞分裂来发挥化疗作用。药物以白蛋白结合形式存在，减少了传统紫杉醇中的溶剂副作用。药效强、输注较安全，在临床上被广泛使用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">02 吡柔比星和环磷酰胺的简要说明\u003C/h2>\n      \u003Cp>\n        吡柔比星属于蒽环类抗生素，主要通过阻断 DNA\n        合成影响细胞增殖，常见于联合化疗方案中。环磷酰胺是烷化剂，通过化学方式干扰细胞功能。这两种药物常协同使用，提高药物疗效。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">03 怎么输注：剂型与用法细节\u003C/h2>\n      \u003Cul class=\"bc-chemo-list\">\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">白蛋白紫杉醇\u003C/span>\n          通常以注射剂型静脉滴注，不能口服。给药前无需激素预处理，这是它的显著优势之一。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">吡柔比星\u003C/span>\n          也以注射方式使用，需在医疗监护下进行，避免漏入血管周围组织。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">环磷酰胺\u003C/span>\n          即可注射，也有片剂供特殊情况选用，但化疗时多采用静脉注射。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：严格按照医生确定的剂量和周期操作，擅自增减剂量会影响药效和安全。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">04 化疗药品如何保存和运输 🧊\u003C/h2>\n      \u003Cul class=\"bc-chemo-list\">\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">白蛋白紫杉醇\u003C/span>\n          需要避光、2-8℃冷藏。药物应原包装密封，避免反复暴露于空气。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">吡柔比星\u003C/span>\n          常温保存，需放在干燥阴凉处，避免高温潮湿。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">环磷酰胺\u003C/span>\n          片剂同样需要避光保存，不可放在卫生间等湿热环境。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>特别提醒：药品应远离儿童，按规定处理剩余药液或过期药品。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">05 化疗期间不能乱吃药\u003C/h2>\n      \u003Cul class=\"bc-chemo-list\">\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">紫杉醇类\u003C/span>\n          不能与地尔硫卓、维拉帕米等强CYP3A4抑制剂同用，会升高血药浓度，增加毒性反应。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">环磷酰胺\u003C/span>\n          避免与氯霉素、华法林等发生相互作用，可能影响抗肿瘤效果和血液系统安全。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">吡柔比星\u003C/span>\n          不建议与其他有心脏毒性的药同用，以防不良心脏事件加剧。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：主动告知医生正在服用的所有药物和保健品，防止药物“打架”。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">06 老年人和肝肾功能受损者的特殊注意 🧑‍🦳\u003C/h2>\n      \u003Cul class=\"bc-chemo-list\">\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">肝功能异常\u003C/span>\n          使用白蛋白紫杉醇和吡柔比星时须减量，避免药物在体内蓄积。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">肾功能不全\u003C/span>\n          环磷酰胺需监测剂量，部分患者可能需要调整或延长给药间隔。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">高龄患者\u003C/span>\n          吸收和代谢能力下降，用药后更应注意血常规和肝肾指标的检测频率。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：如有肝肾异常或65岁以上，请随时与医生沟通具体调整策略。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">07 最常见的不良反应及关键处理办法\u003C/h2>\n      \u003Cul class=\"bc-chemo-list\">\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">白蛋白紫杉醇\u003C/span>\n          最常发生周围神经病变（约30%），表现为手脚麻木。出现时不要自行减药，应及时反馈医生。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">环磷酰胺\u003C/span>\n          可导致恶心、白细胞减少，部分患者有膀胱刺激。严重时要调整剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">吡柔比星\u003C/span>\n          潜在心脏损伤表现为心慌或无力，累计剂量高时需定期做心功能检查。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>出现发热、出血、皮疹等并发，用药后建议定期检查和如实报告不适。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">08 一线用药案例分享\u003C/h2>\n      \u003Cdiv class=\"bc-chemo-case\">\n        \u003Cp>\n          \u003Cspan class=\"bc-chemo-case-title\">典型经验一：\u003C/span>\n          一位40岁女性，在化疗过程中由吡柔比星、环磷酰胺序贯到白蛋白紫杉醇，监测白细胞和神经反应，避免了严重毒副反应，实现化疗全程顺利完成。\n        \u003C/p>\n        \u003Cp>\n          \u003Cspan class=\"bc-chemo-case-title\">典型经验二：\u003C/span>\n          临床有患者应用环磷酰胺时，因未注意药物相互作用，影响了抗肿瘤效果，后来规范药物管理后问题得到改善。\n        \u003C/p>\n      \u003C/div>\n      \u003Cp>\n        \u003Cspan class=\"bc-chemo-case-title\">启发：\u003C/span\n        >用药中主动监测和及时调整，是安全高效使用化疗药物的关键。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">09 化疗药物的剂量管理与漏服处理\u003C/h2>\n      \u003Cul class=\"bc-chemo-list\">\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">注射制剂\u003C/span>\n          每次剂量和间隔周期必须同步记录，严禁擅自提前或推迟注射。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">漏服口服环磷酰胺\u003C/span>\n          可尽快补服，但已到下一个服药周期则跳过，不可双倍剂量补救。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">过量注射\u003C/span>\n          需立即报告医生和护理团队，应急时要准备对症治疗措施。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"bc-chemo-case-title\">正确做法：\u003C/span>\n        维持用药时间表，遇特殊情况第一时间沟通。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">10 开瓶与药液管理的小妙招\u003C/h2>\n      \u003Cul class=\"bc-chemo-list\">\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">连续输注期间\u003C/span>\n          白蛋白紫杉醇稀释后需在8小时内用完，剩余液体作医疗废弃处理。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">吡柔比星\u003C/span>\n          稀释后避免长时间放置，开瓶后尽快使用，保证药效。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">环磷酰胺片剂\u003C/span>\n          拆封后防潮，短期保存勿超30天。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"bc-chemo-case-title\">建议：\u003C/span>\n        各类药品的开瓶/稀释信息应专人记录，杜绝混用和过期使用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">11 辅助用药和健康监测\u003C/h2>\n      \u003Cul class=\"bc-chemo-list\">\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">止吐药\u003C/span>\n          常用昂丹司琼、托烷司琼，按照医生指导定期应用，可预防恶心呕吐。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">电解质溶液\u003C/span>\n          辅助防脱水，服药期间补足液体。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"bc-chemo-list-point\">定期检查\u003C/span>\n          血常规、肝肾功能、电解质指标至少每周期复查1次。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"bc-chemo-case-title\">正确做法：\u003C/span>\n        严格遵从剂量调整和健康指标变化，必要时添加防护药物。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">12 结语：化疗药品用得巧，更安心\u003C/h2>\n      \u003Cp>\n        白蛋白紫杉醇、吡柔比星、环磷酰胺等化疗药物的安全性和有效性，离不开细致规范的操作。请务必记住：剂量、周期、药物储存和相互作用，每一点都该认真落实。遇到不适或者疑问，要及时与医药专家联系。安全用药，关乎每一次的健康进步。\n      \u003C/p>\n      \u003Cdiv class=\"\">\n        \u003Cspan class=\"bc-chemo-case-title\">重点归纳：\u003C/span>\n        维持正确剂量与周期，防范不良反应和药物相互作用，是全程化疗成功的保障。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"bc-chemo-section\">\n    \u003Cdiv class=\"bc-chemo-bg\">\n      \u003Ch2 class=\"bc-chemo-subtitle\">参考文献\u003C/h2>\n      \u003Cul class=\"bc-chemo-ref\">\n        \u003Cli>\n          Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, et al.\n          \u003Ci\n            >Phase III trial of nanoparticle albumin-bound paclitaxel compared\n            with polyethylated castor oil–based paclitaxel in women with breast\n            cancer.\u003C/i\n          >\n          J Clin Oncol. 2005 Oct;23(31):7794-803.\n          \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/16172456/\" target=\"_blank\"\n            >[PubMed]\u003C/a\n          >\n        \u003C/li>\n        \u003Cli>\n          Doyle LA, Yang W, Abruzzo LV, et al.\n          \u003Ci\n            >A multidrug resistance transporter from human MDR1 gene is\n            responsible for resistance to paclitaxel, vinblastine, colchicine,\n            doxorubicin and actinomycin D.\u003C/i\n          >\n          Cancer Res. 1998;58(18):4084-4088.\n          \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/9749484/\" target=\"_blank\"\n            >[PubMed]\u003C/a\n          >\n        \u003C/li>\n        \u003Cli>\n          Emadi A, Jones RJ, Brodsky RA.\n          \u003Ci>Cyclophosphamide and cancer: golden anniversary.\u003C/i> Nat Rev Clin\n          Oncol. 2009 Nov;6(11):638-47.\n          \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/19809536/\" target=\"_blank\"\n            >[PubMed]\u003C/a\n          >\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n  .bc-chemo-container {\n    max-width: 780px;\n    margin: 40px auto;\n    background: #fff;\n    border-radius: 8px;\n    padding: 24px 20px 32px 20px;\n    font-family: \"Segoe UI\", \"Helvetica Neue\", Arial, \"PingFang SC\",\n      \"Microsoft YaHei\", sans-serif;\n    color: #1e2329;\n    box-shadow: 0 4px 28px 0 rgba(33, 68, 101, 0.06),\n      0 2px 4px 0 rgba(33, 68, 101, 0.03);\n    font-size: 17px;\n  }\n\n  .bc-chemo-title {\n    font-size: 2.45rem;\n    font-weight: 700;\n    letter-spacing: 1px;\n    margin-bottom: 36px;\n    color: #274690;\n    text-shadow: 0 2px 9px #eaf4fc;\n  }\n\n  .bc-chemo-section {\n    margin-bottom: 36px;\n  }\n\n  .bc-chemo-section:last-child {\n    margin-bottom: 0;\n  }\n\n  .bc-chemo-subtitle {\n    font-size: 1.4rem;\n    font-weight: 600;\n    margin-bottom: 16px;\n    color: #244165;\n    letter-spacing: 0.5px;\n  }\n\n  .bc-chemo-bg {\n    background: linear-gradient(90deg, #f3f6fa 0%, #e8f4fd 100%);\n    border-radius: 7px;\n    box-shadow: 0 1px 5px 0 rgba(150, 183, 200, 0.1);\n    padding: 24px 18px 17px 18px;\n    margin-bottom: 10px;\n  }\n\n  .bc-chemo-list {\n    margin: 10px 0 17px 24px;\n    padding: 0;\n    list-style: none;\n  }\n\n  .bc-chemo-list li {\n    position: relative;\n    padding-left: 20px;\n    margin-bottom: 9px;\n    line-height: 1.6;\n  }\n\n  .bc-chemo-list-point {\n    color: #0a2533;\n    margin-right: 3px;\n    font-weight: 600;\n  }\n\n  .bc-chemo-list li::before {\n    content: \"💡\";\n    position: absolute;\n    left: -18px;\n    top: 5px;\n    font-size: 18px;\n  }\n\n  .bc-chemo-case {\n    font-size: 1em;\n    margin-bottom: 12px;\n  }\n\n  .bc-chemo-case-title {\n    color: #1c6dde;\n    font-weight: 600;\n    margin-right: 5px;\n  }\n\n  .bc-chemo-tip {\n    display: flex;\n    align-items: center;\n    margin-top: 14px;\n    padding: 12px 14px 11px 14px;\n    background: #e7f2fc;\n    border-left: 6px solid #62a6de;\n    border-radius: 7px;\n    font-size: 1.07em;\n  }\n\n  .bc-chemo-bigemoji {\n    font-size: 2em;\n    margin-right: 10px;\n  }\n\n  .bc-chemo-ref {\n    list-style: decimal;\n    margin-left: 19px;\n    font-size: 1em;\n    color: #274690;\n    padding-left: 11px;\n  }\n\n  .bc-chemo-ref li {\n    margin-bottom: 10px;\n  }\n\n  @media (max-width: 600px) {\n    .bc-chemo-container {\n      padding: 13px 3% 14px 3%;\n      font-size: 15px;\n    }\n    .bc-chemo-title {\n      font-size: 1.45rem;\n    }\n    .bc-chemo-subtitle {\n      font-size: 1.08rem;\n    }\n    .bc-chemo-bg {\n      padding: 12px 6px 10px 9px;\n    }\n  }\n\u003C/style>\n","\u003Cdiv class=\"bc-chemo-container\">\n  \u003Ch1 id=\"material_title\" class=\"bc-chemo-title\">乳腺癌分期2常用化疗药物的安全用药指",539,"2025-12-06 01:16:32"," 乳腺癌分期2常用化疗药物安全用药指南 | 专业用药建议  \n"," 乳腺癌分期2, 化疗药物, 安全用药指南, 乳腺癌治疗, 化疗方案, 药物副作用管理  \n"," 本文提供乳腺癌分期2常用化疗药物的安全用药指南，包括药物选择、剂量调整、副作用管理及注意事项，帮助患者和医护人员确保治疗安全有效。","2025-12-15 14:59:10",2,[35],{"menuId":36,"menuName":37,"parentId":21,"orderNum":33,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]